Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02414009
What this trial is testing

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 82
Testing effectiveness (Phase 2)Study completedNCT01251536
What this trial is testing

Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer

Who this might be right for
Colorectal Cancer
Universitaire Ziekenhuizen KU Leuven 108
Not applicableLooking for participantsNCT07344480
What this trial is testing

Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)Heart FailureRASopathy
Deutsches Herzzentrum Muenchen 100
Early research (Phase 1)Looking for participantsNCT06804824
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vividion Therapeutics, Inc. 220
Early research (Phase 1)Ended earlyNCT06270082
What this trial is testing

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Cancer+7 more
Ikena Oncology 75
Testing effectiveness (Phase 2)UnknownNCT04653480
What this trial is testing

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

Who this might be right for
Colorectal Cancer
Zhejiang University 61
Not applicableWithdrawnNCT03278639
What this trial is testing

Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease

Who this might be right for
Parkinson Disease
Pontifical Catholic University of Argentina
Testing effectiveness (Phase 2)UnknownNCT04169347
What this trial is testing

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Criterium, Inc. 27
Testing effectiveness (Phase 2)UnknownNCT05842525
What this trial is testing

Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hunan Cancer Hospital 42
Not applicableStudy completedNCT03974490
What this trial is testing

Effect of RAS on Balance and Gait After Stroke

Who this might be right for
StrokeGait, HemiplegicGait Disorders, Neurologic
Hospital Sociosanitari Mutuam Girona 55
Testing effectiveness (Phase 2)UnknownNCT05634590
What this trial is testing

The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fudan University 68
Large-scale testing (Phase 3)Active Not RecruitingNCT04854668
What this trial is testing

Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 748
Early research (Phase 1)Looking for participantsNCT06096974
What this trial is testing

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Who this might be right for
Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd. 60
Post-approval studies (Phase 4)Study completedNCT03690544
What this trial is testing

Apremilast for RAS

Who this might be right for
Recurrent Aphthous Stomatitis
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT01668498
What this trial is testing

Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer

Who this might be right for
Ras-wildtype Colorectal Cancer
AIO-Studien-gGmbH 88
Testing effectiveness (Phase 2)Ended earlyNCT01322815
What this trial is testing

A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI

Who this might be right for
Colon Cancer
Georgetown University 11
Not applicableUnknownNCT01855815
What this trial is testing

Hemolung RAS Registry Program

Who this might be right for
Acute Hypercapnic Respiratory Failure
Alung Technologies 99
Large-scale testing (Phase 3)Active Not RecruitingNCT04793958
What this trial is testing

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Who this might be right for
Advanced Colorectal CancerMetastatic Colorectal Cancer
Mirati Therapeutics Inc. 461
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Early research (Phase 1)Looking for participantsNCT07638371
What this trial is testing

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

Who this might be right for
Solid TumorSolid CarcinomaAdvanced Solid Tumor+2 more
Memorial Sloan Kettering Cancer Center 16
Next Page